These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 26126423)

  • 1. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection.
    Wakayama K; Kamiyama T; Yokoo H; Orimo T; Shimada S; Einama T; Kamachi H; Taketomi A
    J Surg Oncol; 2017 Mar; 115(3):324-329. PubMed ID: 28192617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hepatectomy for huge hepatocellular carcinoma (≥ 10 cm in diameter) safe and effective? A single-center experience.
    Yang J; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    Asian Pac J Cancer Prev; 2014; 15(17):7069-77. PubMed ID: 25227793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.
    Zheng J; Kuk D; Gönen M; Balachandran VP; Kingham TP; Allen PJ; D'Angelica MI; Jarnagin WR; DeMatteo RP
    Ann Surg Oncol; 2017 May; 24(5):1358-1366. PubMed ID: 27921192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
    Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
    Li SP; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
    Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
    Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.
    Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS
    Br J Surg; 2007 Mar; 94(3):320-6. PubMed ID: 17205495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    J Gastrointest Surg; 2015 Jul; 19(7):1281-90. PubMed ID: 25956724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.
    Hwang S; Joh JW; Wang HJ; Kim DG; Kim KS; Suh KS; Kim SH; Yu HC; Cho CK; Lee YJ; Kim KH; Kim JM; Kim BW; Lee SG
    World J Surg; 2018 Aug; 42(8):2579-2591. PubMed ID: 29340726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
    Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
    Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size.
    Sasaki K; Matsuda M; Ohkura Y; Kawamura Y; Inoue M; Hashimoto M; Ikeda K; Kumada H; Watanabe G
    World J Surg; 2015 May; 39(5):1134-41. PubMed ID: 25287916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma.
    Park YK; Song SK; Kim BW; Park SK; Chung CW; Wang HJ
    World J Surg Oncol; 2017 Dec; 15(1):225. PubMed ID: 29258507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
    Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
    J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.